Machine learning-based diagnostic method of pre-therapeutic 18F-FDG PET/CT for evaluating mediastinal lymph nodes in non-small cell lung cancer
Authors:
- 25 November 2020
- journal article
- research article
- Published by Springer Nature in European Radiology
- Vol. 31 (6) , 4184-4194
Abstract
Objectives We aimed to find the best machine learning (ML) model using 18F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for evaluating metastatic mediastinal lymph nodes (MedLNs) in non-small cell lung cancer, and compare the diagnostic results with those of nuclear medicine physicians. Methods A total of 1329 MedLNs were reviewed. Boosted decision tree, logistic regression, support vector machine, neural network, and decision forest models were compared. The diagnostic performance of the best ML model was compared with that of physicians. The ML method was divided into ML with quantitative variables only (MLq) and adding clinical information (MLc). We performed an analysis based on the 18F-FDG-avidity of the MedLNs. Results The boosted decision tree model obtained higher sensitivity and negative predictive values but lower specificity and positive predictive values than the physicians. There was no significant difference between the accuracy of the physicians and MLq (79.8% vs. 76.8%, p = 0.067). The accuracy of MLc was significantly higher than that of the physicians (81.0% vs. 76.8%, p = 0.009). In MedLNs with low 18F-FDG-avidity, ML had significantly higher accuracy than the physicians (70.0% vs. 63.3%, p = 0.018). Conclusion Although there was no significant difference in accuracy between the MLq and physicians, the diagnostic performance of MLc was better than that of MLq or of the physicians. The ML method appeared to be useful for evaluating low metabolic MedLNs. Therefore, adding clinical information to the quantitative variables from 18F-FDG PET/CT can improve the diagnostic results of ML. Key Points • Machine learning using two-class boosted decision tree model revealed the highest value of area under curve, and it showed higher sensitivity and negative predictive values but lower specificity and positive predictive values than nuclear medicine physicians. • The diagnostic results from machine learning method after adding clinical information to the quantitative variables improved accuracy significantly than nuclear medicine physicians. • Machine learning could improve the diagnostic significance of metastatic mediastinal lymph nodes, especially in mediastinal lymph nodes with low 18F-FDG-avidity.Keywords
Funding Information
- VHS Medical Center Research Grant, Republic of Korea (VHSMC 19037)
- National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2019R1F1A1062243, NRF-2019R1H1A2039688)
This publication has 36 references indexed in Scilit:
- Implications of False Negative and False Positive Diagnosis in Lymph Node Staging of NSCLC by Means of 18F-FDG PET/CTPLOS ONE, 2013
- Retrospective Analysis of Nodal Spread Patterns According to Tumor Location in Pathological N2 Non‐small Cell Lung CancerWorld Journal of Surgery, 2012
- Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter studyRadiotherapy and Oncology, 2012
- Positron Emission Tomography-Computed Tomography Compared with Invasive Mediastinal Staging in Non-small Cell Lung Cancer: Results of Mediastinal Staging in the Early Lung Positron Emission Tomography TrialJournal of Thoracic Oncology, 2011
- Occult nodal metastasis in patients with non‐small cell lung cancer at clinical stage IA by PET/CTRespirology, 2010
- Endobronchial ultrasound-guided transbronchial needle aspiration for staging of lung cancer: A systematic review and meta-analysisEuropean Journal of Cancer, 2009
- Correlation of intra-tumour heterogeneity on 18F-FDG PET with pathologic features in non-small cell lung cancer: A feasibility studyRadiotherapy and Oncology, 2008
- Real-Time Endobronchial Ultrasound-Guided Transbronchial Lymph Node AspirationThe Annals of Thoracic Surgery, 2008
- Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F‐FDG PET/CT in a tuberculosis‐endemic countryCancer, 2007
- The clinical stage of non–small cell lung cancer as assessed by means of fluorodeoxyglucose–positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokersThe Journal of Thoracic and Cardiovascular Surgery, 2006